Pruritus (Juckreiz) bei Psoriasis

  • PSORITUS (CAIN457ADE03)
  • Exploratory study on kinetics of pruritus intensity and lesional remission in psoriasis patients treated with subcutenous secukinumab (300 mg) during a 16 week run-in-phase followed by a 16 week randomized withdrawal period in a double-blind, placebo-controlled design
  • Studie beendet

Letzte Aktualisierung:
07. Mai 2021

Aktualisierte Beiträge:

  • Interventionelle Studien
  • Nicht-interventionelle Studien
  • Wissenschaftliche Vorträge
  • Stellenangebote